Skip to content

Medication Safety in Hospitalized Patients: Understanding Severe Adverse Reactions and Their Risks

Clinical Characteristics and Risk Factors Analysis of Severe Adverse Drug Reactions in Hospitalized Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600118466
Enrollment
Unknown
Registered
2026-02-05
Start date
2026-02-09
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

This study does not target a single specific disease, but focuses on all types of severe adverse clinical events caused by medications. Commonly affected organ systems include, but are not limited to: Skin and Appendage Damage: e.g., Stevens-Johnson syndrome, toxic epidermal necrolysis. Systemic Damage: e.g., anaphylactic shock, drug fever. Hepatobiliary System Damage: e.g., severe drug-i

Interventions

Observation group:None

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Occurrence of a drug adverse event meeting the criteria for a Severe Adverse Drug Reaction (ADR) during hospitalization at our institution. 2.Availability of complete medical records allowing for the retrieval of detailed information regarding the ADR diagnosis, management, and clinical outcome.

Exclusion criteria

Exclusion criteria: 1.The ADR event occurred before admission or after discharge. 2.The ADR event was a mild reaction (e.g., Grade 1 nausea, headache) not requiring medical intervention. 3.Severely incomplete medical records that preclude a reliable causality assessment;

Design outcomes

Primary

MeasureTime frame
Incidence and Profile of Severe ADRs;

Countries

China

Contacts

Public ContactWei-Jing Gong

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

weijinggong@hust.edu.cn+86 181 5431 1279

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026